394 articles in this topic
Massive study of 127,000 women shows PCOS significantly raises cardiovascular disease risk across all weight categories.
New research reveals obesity worsens menopause symptoms and hormone therapy risks, calling for integrated treatment approaches.
New analysis highlights significant research gaps and methodological issues in studies examining testosterone therapy health outcomes.
Scientists respond to methodological concerns about testosterone therapy research in transgender men, addressing study design questions.
New analysis shows adrenalectomy more effective than drugs at reducing dangerous heart muscle thickening in primary aldosteronism patients.
New clinical guidance emphasizes obesity treatment as essential for comprehensive menopause care and long-term health outcomes.
Study reveals 80% of adrenal cancer patients need psychological support, with high rates of depression and anxiety regardless of tumor status.
New research reveals daily hassles and heightened cortisol sensitivity each separately increase cardiovascular disease odds by 36-38%.
German study of 11,863 survivors reveals 31% develop hormone disorders vs 16% in general population, with hypothyroidism most common.
Teprotumumab successfully treated severe pretibial dermopathy in five patients, offering hope for this disfiguring autoimmune skin condition.
Lenvatinib plus pembrolizumab combination therapy demonstrated 36% response rate in patients with deadly anaplastic thyroid cancer.
Six AI platforms cleared by FDA demonstrate good performance in thyroid nodule assessment, especially compared to less-experienced physicians.
